comparative evaluation of rapid tests, hiv specific peptide eia and western blot test for diagnosis...

1
POSTER PRESENTATION Open Access Comparative evaluation of rapid tests, HIV specific peptide EIA and Western Blot test for diagnosis of HIV-2 and HIV 1&2 infection Jayanthi Shastri 1* , Sachee Agrawal 1 , Sandhya Sawant 1 , Manish Pathak 1 , Bharat Parekh 2 From First International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2012) Chennai, India. 20-22 January 2012 Background In 1986, a second type of HIV, called HIV-2, was iso- lated from AIDS patients in West Africa, where it may have been present decades earlier. HIV-2 infections are predominantly found in Africa. West African nations report a prevalence of HIV-2 infection of more than 1% in the general population. The prevalence rate of HIV-2 infection in India is not available so far as HIV-2 infec- tions are underreported in India. The currently used Rapid Antibody diagnostic tests when used singly are unable to specifically detect HIV-2 and HIV 1&2 infec- tions. Hence the present study was undertaken to speci- fically detect HIV-2 and HIV 1&2 infections and validate the currently used Rapid test kits using HIV specific peptide EIA and Western Blot test for diagnosis of HIV-2 and HIV 1&2 infection. Methods A total of 37 serum samples (18 HIV-2 and 19 HIV 1&2) were evaluated by using HIV specific peptide EIA (CDC Atlanta, USA) and Western Blot test. All these 37 samples were diagnosed HIV-2 and HIV 1&2 as per the guidelines laid down by the National AIDS Control Organization (NACO), India. Results 100% concordance was observed in the results of Rapid tests, EIA test and Western Blot test. Conclusion Under all circumstances screening for diagnosis of HIV should be based on three different tests with three dif- ferent antigenic principles. Using above protocol it is possible to detect HIV-2 and HIV 1&2 infections. Author details 1 Department of Microbiology, Topiwala National Medical College & B. Y. L. Nair Ch. Hospital, Mumbai, India. 2 Centers for Disease Control & Prevention, Atlanta, USA. Published: 4 May 2012 doi:10.1186/1471-2334-12-S1-P20 Cite this article as: Shastri et al.: Comparative evaluation of rapid tests, HIV specific peptide EIA and Western Blot test for diagnosis of HIV-2 and HIV 1&2 infection. BMC Infectious Diseases 2012 12(Suppl 1):P20. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit * Correspondence: [email protected] 1 Department of Microbiology, Topiwala National Medical College & B. Y. L. Nair Ch. Hospital, Mumbai, India Full list of author information is available at the end of the article Shastri et al. BMC Infectious Diseases 2012, 12(Suppl 1):P20 http://www.biomedcentral.com/1471-2334/12/S1/P20 © 2012 Shastri et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Upload: manish-pathak

Post on 01-Oct-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

POSTER PRESENTATION Open Access

Comparative evaluation of rapid tests, HIVspecific peptide EIA and Western Blot test fordiagnosis of HIV-2 and HIV 1&2 infectionJayanthi Shastri1*, Sachee Agrawal1, Sandhya Sawant1, Manish Pathak1, Bharat Parekh2

From First International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2012)Chennai, India. 20-22 January 2012

BackgroundIn 1986, a second type of HIV, called HIV-2, was iso-lated from AIDS patients in West Africa, where it mayhave been present decades earlier. HIV-2 infections arepredominantly found in Africa. West African nationsreport a prevalence of HIV-2 infection of more than 1%in the general population. The prevalence rate of HIV-2infection in India is not available so far as HIV-2 infec-tions are underreported in India. The currently usedRapid Antibody diagnostic tests when used singly areunable to specifically detect HIV-2 and HIV 1&2 infec-tions. Hence the present study was undertaken to speci-fically detect HIV-2 and HIV 1&2 infections andvalidate the currently used Rapid test kits using HIVspecific peptide EIA and Western Blot test for diagnosisof HIV-2 and HIV 1&2 infection.

MethodsA total of 37 serum samples (18 HIV-2 and 19 HIV1&2) were evaluated by using HIV specific peptide EIA(CDC Atlanta, USA) and Western Blot test. All these 37samples were diagnosed HIV-2 and HIV 1&2 as per theguidelines laid down by the National AIDS ControlOrganization (NACO), India.

Results100% concordance was observed in the results of Rapidtests, EIA test and Western Blot test.

ConclusionUnder all circumstances screening for diagnosis of HIVshould be based on three different tests with three dif-ferent antigenic principles. Using above protocol it ispossible to detect HIV-2 and HIV 1&2 infections.

Author details1Department of Microbiology, Topiwala National Medical College & B. Y. L.Nair Ch. Hospital, Mumbai, India. 2Centers for Disease Control & Prevention,Atlanta, USA.

Published: 4 May 2012

doi:10.1186/1471-2334-12-S1-P20Cite this article as: Shastri et al.: Comparative evaluation of rapid tests,HIV specific peptide EIA and Western Blot test for diagnosis of HIV-2and HIV 1&2 infection. BMC Infectious Diseases 2012 12(Suppl 1):P20.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

* Correspondence: [email protected] of Microbiology, Topiwala National Medical College & B. Y. L.Nair Ch. Hospital, Mumbai, IndiaFull list of author information is available at the end of the article

Shastri et al. BMC Infectious Diseases 2012, 12(Suppl 1):P20http://www.biomedcentral.com/1471-2334/12/S1/P20

© 2012 Shastri et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited.